VERAPAMIL HYDROCHLORIDE

VERAPAMIL HYDROCHLORIDE was reported 4314 times

VERAPAMIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOPULMONARY EXERCISE TEST ABNORMAL 12 0.4286
1 MENISCOPATHY 11 0.2444
2 PELVIC MISALIGNMENT 11 0.2157
3 FACTOR VII DEFICIENCY 12 0.1791
4 AMAUROSIS FUGAX 148 0.1374
5 NEOVASCULARISATION 35 0.1331
6 HYPOGLOBULINAEMIA 13 0.1150
7 PERONEAL NERVE INJURY 12 0.1062
8 SACROILIAC JOINT DYSFUNCTION 12 0.0902
9 NEUROFIBROMA 12 0.0800
10 GASTROINTESTINAL DYSPLASIA 9 0.0744
11 CEREBRAL ARTERY THROMBOSIS 29 0.0564
12 VENTRICULAR ENLARGEMENT 9 0.0511
13 SMALL INTESTINE ADENOCARCINOMA 9 0.0503
14 BRAIN SCAN ABNORMAL 28 0.0502
15 GAMMOPATHY 9 0.0497
16 DEVICE PACING ISSUE 4 0.0471
17 MESENTERIC ABSCESS 3 0.0462
18 MERYCISM 12 0.0420
19 RECTAL NEOPLASM 9 0.0344
20 POST-TRAUMATIC HEADACHE 5 0.0318
21 MYOCARDIAL STUNNING 4 0.0299
22 MYOSCLEROSIS 11 0.0298
23 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 5 0.0298
24 BRASH SYNDROME 38 0.0271
25 URINARY TRACT DISORDER 122 0.0271
26 GASTROINTESTINAL TRACT ADENOMA 9 0.0247
27 PURPURA SENILE 3 0.0246
28 HAEMODIALYSIS COMPLICATION 4 0.0235
29 ATRIOVENTRICULAR DISSOCIATION 5 0.0234
30 PATELLOFEMORAL PAIN SYNDROME 12 0.0233
31 JOINT HYPEREXTENSION 9 0.0231
32 VESTIBULAR NEURONITIS 12 0.0225
33 SINONASAL OBSTRUCTION 9 0.0224
34 NEUROGENIC SHOCK 12 0.0221
35 CEREBRAL VENTRICULAR RUPTURE 4 0.0219
36 SPHINCTER OF ODDI DYSFUNCTION 9 0.0218
37 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
38 HELICOBACTER TEST POSITIVE 12 0.0214
39 BIFASCICULAR BLOCK 4 0.0214
40 HAEMORRHAGIC STROKE 163 0.0209
41 STASIS DERMATITIS 14 0.0205
42 CERVICOBRACHIAL SYNDROME 12 0.0196
43 RHYTHM IDIOVENTRICULAR 6 0.0185
44 TRACHEAL DISORDER 9 0.0173
45 VASOPLEGIA SYNDROME 28 0.0171
46 ORTHOSTATIC INTOLERANCE 12 0.0167
47 BODY FAT DISORDER 9 0.0166
48 MEDICATION OVERUSE HEADACHE 14 0.0164
49 NODAL RHYTHM 23 0.0157
50 LOW CARDIAC OUTPUT SYNDROME 5 0.0150
51 PUTAMEN HAEMORRHAGE 4 0.0140
52 GASTROINTESTINAL NEOPLASM 12 0.0139
53 OBSTRUCTIVE SLEEP APNOEA SYNDROME 20 0.0137
54 OCULAR DISCOMFORT 149 0.0133
55 EXTENSOR PLANTAR RESPONSE 12 0.0130
56 BREATHING-RELATED SLEEP DISORDER 3 0.0127
57 SOLAR LENTIGO 12 0.0126
58 ARRHYTHMIC STORM 4 0.0120
59 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 4 0.0115
60 OSTEOCHONDROSIS 13 0.0112
61 PLEURAL DISORDER 7 0.0111
62 AREFLEXIA 29 0.0109
63 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
64 AORTIC DILATATION 12 0.0108
65 INTENTIONAL MISUSE 20 0.0105
66 ADENOMA BENIGN 9 0.0105
67 NODAL ARRHYTHMIA 9 0.0105
68 GENERALISED OEDEMA 129 0.0104
69 NON-CARDIOGENIC PULMONARY OEDEMA 11 0.0104
70 ANAEMIA VITAMIN B12 DEFICIENCY 5 0.0101
71 DILATED CARDIOMYOPATHY 10 0.0099
72 PYRAMIDAL TRACT SYNDROME 4 0.0095
73 PARADOXICAL DRUG REACTION 35 0.0095
74 ATRIOVENTRICULAR BLOCK COMPLETE 63 0.0094
75 COLON NEOPLASM 9 0.0093
76 HEAD DISCOMFORT 157 0.0089
77 SINUS NODE DYSFUNCTION 16 0.0087
78 PULMONARY VALVE INCOMPETENCE 12 0.0082
79 ECLAMPSIA 3 0.0082
80 KNEE DEFORMITY 12 0.0081
81 RUBBER SENSITIVITY 12 0.0078
82 ALTERED STATE OF CONSCIOUSNESS 169 0.0078
83 CARDIOGENIC SHOCK 111 0.0077
84 NEOPLASM SKIN 12 0.0077
85 BRONCHITIS ACUTE 3 0.0075
86 FOETAL HYPOKINESIA 5 0.0071
87 COMA SCALE ABNORMAL 20 0.0069
88 THALAMUS HAEMORRHAGE 6 0.0069
89 AORTIC VALVE INCOMPETENCE 29 0.0068
90 MONOPARESIS 12 0.0066
91 DISTRIBUTIVE SHOCK 15 0.0066
92 PHOTOPHOBIA 124 0.0066
93 ASPIRATION PLEURAL CAVITY 5 0.0065
94 HAEMATEMESIS 160 0.0063
95 OEDEMA GENITAL 4 0.0063
96 MESOTHELIOMA 8 0.0062
97 COMPARTMENT SYNDROME 16 0.0061
98 EXFOLIATIVE RASH 16 0.0061
99 ANURIA 52 0.0060
100 PRINZMETAL ANGINA 6 0.0060
101 MYOCARDIAL NECROSIS MARKER INCREASED 10 0.0060
102 LICHEN SCLEROSUS 4 0.0058
103 ATRIOVENTRICULAR BLOCK SECOND DEGREE 17 0.0056
104 MIGRAINE WITH AURA 15 0.0055
105 SEBORRHOEIC KERATOSIS 8 0.0055
106 PRESYNCOPE 134 0.0055
107 ASCITES 162 0.0055
108 METABOLIC SYNDROME 9 0.0055
109 BRAIN CONTUSION 4 0.0055
110 PULSE ABSENT 26 0.0055
111 VASOSPASM 5 0.0054
112 PERIARTHRITIS 12 0.0053
113 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 27 0.0053
114 ATRIOVENTRICULAR BLOCK 40 0.0052
115 CLUSTER HEADACHE 7 0.0051
116 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
117 AMBLYOPIA 3 0.0051
118 ACTINIC KERATOSIS 13 0.0050
119 DYSPNOEA AT REST 14 0.0048
120 ANION GAP 3 0.0047
121 CARDIO-RESPIRATORY ARREST 198 0.0047
122 DIPLOPIA 119 0.0046
123 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
124 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0045
125 SINUS ARREST 7 0.0045
126 CHONDROPATHY 12 0.0044
127 COMA 209 0.0044
128 HEPATITIS FULMINANT 13 0.0044
129 SICK SINUS SYNDROME 5 0.0043
130 MIXED LIVER INJURY 13 0.0043
131 BUNDLE BRANCH BLOCK LEFT 18 0.0042
132 HAEMATURIA 144 0.0042
133 CHOLESTATIC LIVER INJURY 9 0.0040
134 SKIN EROSION 13 0.0040
135 MULTIPLE DRUG OVERDOSE 20 0.0040
136 BRADYCARDIA 213 0.0040
137 GINGIVAL HYPERTROPHY 6 0.0040
138 ATRIOVENTRICULAR BLOCK FIRST DEGREE 17 0.0039
139 GOITRE 16 0.0039
140 DISCOURAGEMENT 9 0.0038
141 ESCHERICHIA BACTERAEMIA 9 0.0038
142 BLINDNESS 156 0.0038
143 SMALL INTESTINAL PERFORATION 7 0.0037
144 HEMIPLEGIA 31 0.0037
145 PERICARDIAL HAEMORRHAGE 8 0.0037
146 DRY AGE-RELATED MACULAR DEGENERATION 4 0.0036
147 DEATH NEONATAL 5 0.0036
148 RENAL TUBULAR DISORDER 10 0.0036
149 EMBOLIC STROKE 12 0.0034
150 COMMUNICATION DISORDER 13 0.0034
151 SHOCK 76 0.0033
152 FACIAL PARALYSIS 28 0.0033
153 EJECTION FRACTION ABNORMAL 4 0.0033
154 HYPERTENSIVE HEART DISEASE 6 0.0032
155 PROTHROMBIN LEVEL DECREASED 3 0.0032
156 PCO2 DECREASED 3 0.0031
157 CARDIOACTIVE DRUG LEVEL INCREASED 4 0.0030
158 INTERVERTEBRAL DISC DISORDER 13 0.0030
159 TRICUSPID VALVE INCOMPETENCE 24 0.0030
160 VENTRICULAR ARRHYTHMIA 11 0.0030
161 ACQUIRED HAEMOPHILIA 3 0.0030
162 POTENTIATING DRUG INTERACTION 10 0.0030
163 PERIPHERAL VENOUS DISEASE 12 0.0029
164 SNORING 11 0.0029
165 ATRIAL THROMBOSIS 6 0.0029
166 VASCULAR PURPURA 4 0.0029
167 ALOPECIA AREATA 5 0.0028
168 COMPLETED SUICIDE 236 0.0028
169 TINNITUS 130 0.0028
170 CARDIAC FAILURE CHRONIC 12 0.0028
171 CORONARY ARTERY STENOSIS 14 0.0028
172 PRODUCT MONITORING ERROR 4 0.0028
173 MELANOCYTIC NAEVUS 12 0.0027
174 CARDIAC FIBRILLATION 4 0.0027
175 NEPHROSCLEROSIS 3 0.0027
176 EYE PAIN 152 0.0027
177 CARDIAC DYSFUNCTION 10 0.0027
178 BLOOD PRESSURE IMMEASURABLE 4 0.0026
179 PO2 DECREASED 3 0.0026
180 ACUTE RESPIRATORY DISTRESS SYNDROME 46 0.0026
181 AORTIC THROMBOSIS 3 0.0026
182 TACHYCARDIA 230 0.0026
183 SINUS BRADYCARDIA 25 0.0026
184 HYPERTROPHIC CARDIOMYOPATHY 4 0.0026
185 GASTRITIS EROSIVE 12 0.0026
186 HYPERTENSIVE EMERGENCY 3 0.0025
187 OCCULT BLOOD POSITIVE 5 0.0025
188 ACUTE LUNG INJURY 3 0.0025
189 SINUS HEADACHE 15 0.0025
190 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
191 METABOLIC ALKALOSIS 4 0.0025
192 MENISCUS INJURY 15 0.0024
193 BRADYARRHYTHMIA 4 0.0024
194 ARTERIOSCLEROSIS CORONARY ARTERY 16 0.0024
195 CEREBELLAR INFARCTION 4 0.0024
196 CARDIOPULMONARY FAILURE 9 0.0023
197 VITREOUS DETACHMENT 5 0.0023
198 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
199 ISCHAEMIC STROKE 41 0.0023
200 GASTROINTESTINAL OEDEMA 4 0.0023
201 INTERNATIONAL NORMALISED RATIO DECREASED 9 0.0022
202 VENTRICULAR EXTRASYSTOLES 23 0.0022
203 BEZOAR 3 0.0022
204 FOETAL GROWTH RESTRICTION 13 0.0021
205 HYPOGAMMAGLOBULINAEMIA 14 0.0021
206 PERONEAL NERVE PALSY 12 0.0021
207 HAEMODYNAMIC INSTABILITY 16 0.0021
208 LUMBAR SPINAL STENOSIS 6 0.0021
209 HAEMORRHOIDAL HAEMORRHAGE 10 0.0020
210 HEPATIC FIBROSIS 7 0.0020
211 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
212 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
213 TACHYARRHYTHMIA 5 0.0020
214 VENTRICULAR HYPERTROPHY 5 0.0020
215 DRUG INTERACTION 316 0.0020
216 SMALL INTESTINAL HAEMORRHAGE 4 0.0020
217 TOXIC SKIN ERUPTION 20 0.0020
218 KERATITIS 6 0.0020
219 DIVERTICULUM 14 0.0020
220 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
221 INCREASED BRONCHIAL SECRETION 5 0.0020
222 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
223 ILEUS 24 0.0019
224 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
225 CUTANEOUS VASCULITIS 7 0.0019
226 BLOOD CREATININE DECREASED 6 0.0019
227 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
228 METABOLIC ACIDOSIS 60 0.0019
229 LEUKOCYTOCLASTIC VASCULITIS 3 0.0018
230 REACTION TO DRUG EXCIPIENTS 4 0.0018
231 DIVERTICULUM INTESTINAL 8 0.0018
232 INGUINAL HERNIA 11 0.0018
233 CEREBRAL HAEMATOMA 6 0.0018
234 TORSADE DE POINTES 14 0.0018
235 HYPERKALAEMIA 62 0.0018
236 ATELECTASIS 17 0.0018
237 LICHENOID KERATOSIS 4 0.0017
238 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
239 PSEUDOMONAL SEPSIS 3 0.0017
240 SEPSIS 189 0.0017
241 EXTRAPYRAMIDAL DISORDER 42 0.0017
242 CEREBRAL INFARCTION 41 0.0017
243 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
244 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
245 LONG QT SYNDROME 4 0.0017
246 QUALITY OF LIFE DECREASED 22 0.0016
247 AMYLASE INCREASED 6 0.0016
248 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
249 PUPILLARY REFLEX IMPAIRED 3 0.0016
250 ABDOMINAL TENDERNESS 8 0.0016
251 INTENTIONAL OVERDOSE 103 0.0016
252 ACUTE PULMONARY OEDEMA 9 0.0016
253 SPINAL OSTEOARTHRITIS 14 0.0016
254 MITRAL VALVE INCOMPETENCE 18 0.0016
255 HYPOPROTEINAEMIA 3 0.0016
256 HYPOMAGNESAEMIA 22 0.0016
257 RESPIRATORY RATE INCREASED 14 0.0016
258 SEDATION COMPLICATION 4 0.0016
259 VENTRICULAR HYPOKINESIA 5 0.0016
260 OESOPHAGITIS 17 0.0016
261 PHYSICAL DECONDITIONING 4 0.0016
262 AORTIC ARTERIOSCLEROSIS 4 0.0016
263 DRUG TOXICITY 21 0.0015
264 SYNCOPE 154 0.0015
265 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
266 POLYARTHRITIS 8 0.0015
267 LACTIC ACIDOSIS 49 0.0015
268 CARDIAC FAILURE ACUTE 10 0.0015
269 CHOLECYSTITIS CHRONIC 10 0.0015
270 ELECTROLYTE IMBALANCE 17 0.0015
271 SPINAL STENOSIS 6 0.0015
272 RESPIRATORY DISTRESS 40 0.0014
273 LIVEDO RETICULARIS 3 0.0014
274 HYPOTENSION 287 0.0014
275 ATRIAL TACHYCARDIA 3 0.0014
276 BREAST PAIN 15 0.0014
277 PERIODONTITIS 3 0.0014
278 ATRIAL FLUTTER 11 0.0014
279 HENOCH-SCHONLEIN PURPURA 3 0.0014
280 EOSINOPHILIA 24 0.0014
281 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
282 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
283 PULMONARY CONGESTION 18 0.0014
284 NECK INJURY 4 0.0014
285 NERVE INJURY 15 0.0013
286 HYPERCHOLESTEROLAEMIA 13 0.0013
287 FACIAL PAIN 12 0.0013
288 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
289 IDIOPATHIC INTRACRANIAL HYPERTENSION 3 0.0013
290 HYPERCAPNIA 4 0.0013
291 BLOOD PRESSURE INCREASED 203 0.0013
292 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
293 BODY TEMPERATURE DECREASED 13 0.0013
294 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
295 NOCTURIA 16 0.0013
296 ATRIAL FIBRILLATION 128 0.0013
297 CHILLS 153 0.0013
298 RENAL FAILURE CHRONIC 10 0.0013
299 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 71 0.0013
300 CIRCULATORY COLLAPSE 22 0.0013
301 OLIGURIA 8 0.0013
302 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
303 EOSINOPHILIC PNEUMONIA 4 0.0013
304 POISONING DELIBERATE 12 0.0013
305 VENTRICULAR FIBRILLATION 14 0.0013
306 MULTIPLE DRUG OVERDOSE INTENTIONAL 4 0.0012
307 MYOCARDITIS 14 0.0012
308 LISTLESS 4 0.0012
309 CYANOSIS 19 0.0012
310 CYTOLYTIC HEPATITIS 4 0.0012
311 RETINAL ARTERY OCCLUSION 3 0.0012
312 COLITIS ISCHAEMIC 8 0.0012
313 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
314 TOXIC ENCEPHALOPATHY 6 0.0012
315 ROTATOR CUFF SYNDROME 15 0.0012
316 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
317 TOXICITY TO VARIOUS AGENTS 196 0.0012
318 LEFT VENTRICULAR FAILURE 4 0.0012
319 ANGINA PECTORIS 33 0.0012
320 CARDIOMEGALY 14 0.0011
321 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
322 JOINT DISLOCATION 12 0.0011
323 SUDDEN DEATH 12 0.0011
324 RESPIRATORY FAILURE 82 0.0011
325 HAEMORRHAGIC DIATHESIS 4 0.0011
326 MYOSITIS 10 0.0011
327 HEART RATE DECREASED 39 0.0011
328 SHOCK HAEMORRHAGIC 9 0.0011
329 HYDROCEPHALUS 6 0.0011
330 ASPIRATION 12 0.0011
331 INTESTINAL ISCHAEMIA 6 0.0011
332 ALCOHOL USE 4 0.0011
333 MOTOR DYSFUNCTION 11 0.0011
334 NEPHROGENIC ANAEMIA 5 0.0011
335 HEART RATE ABNORMAL 6 0.0011
336 BURSITIS 13 0.0011
337 ANAL HAEMORRHAGE 3 0.0011
338 NEPHROPATHY 10 0.0011
339 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
340 RHABDOMYOLYSIS 44 0.0011
341 MYOCARDIAL ISCHAEMIA 12 0.0011
342 ABDOMINAL PAIN 245 0.0011
343 PNEUMATOSIS INTESTINALIS 3 0.0011
344 HYPOXIA 37 0.0010
345 ACIDOSIS 8 0.0010
346 ARRHYTHMIA 49 0.0010
347 METABOLIC DISORDER 6 0.0010
348 GASTROINTESTINAL NECROSIS 3 0.0010
349 DRUG LEVEL INCREASED 17 0.0010
350 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
351 CARDIAC ARREST 84 0.0010
352 DRUG ERUPTION 18 0.0010
353 HYPERVOLAEMIA 5 0.0010
354 MYOCLONUS 12 0.0010
355 HAEMATOMA 26 0.0010
356 PROTHROMBIN TIME PROLONGED 6 0.0010
357 ARTERIOSPASM CORONARY 4 0.0010
358 CEREBROVASCULAR DISORDER 3 0.0010
359 VISION BLURRED 136 0.0010
360 MYASTHENIA GRAVIS 8 0.0010
361 HYPERGLYCAEMIA 36 0.0010
362 HYPERURICAEMIA 4 0.0010
363 DIASTOLIC DYSFUNCTION 3 0.0010
364 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
365 BLOOD PRESSURE DECREASED 63 0.0009
366 MUSCLE FATIGUE 4 0.0009
367 PHARYNGOLARYNGEAL PAIN 5 0.0009
368 SOMNOLENCE 189 0.0009
369 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
370 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
371 CARDIAC FAILURE 74 0.0009
372 OEDEMA MOUTH 3 0.0009
373 HEPATOCELLULAR INJURY 13 0.0009
374 HYPERTHERMIA 7 0.0009
375 HAEMORRHAGIC ANAEMIA 4 0.0009
376 DYSPNOEA EXERTIONAL 34 0.0009
377 GASTRIC ULCER HAEMORRHAGE 5 0.0009
378 POST-TRAUMATIC STRESS DISORDER 6 0.0009
379 EMPHYSEMA 9 0.0009
380 HEART RATE IRREGULAR 20 0.0009
381 MYALGIA 149 0.0009
382 POISONING 11 0.0009
383 DEPRESSION SUICIDAL 3 0.0009
384 IRON DEFICIENCY ANAEMIA 8 0.0009
385 HYPOPNOEA 3 0.0009
386 MELAENA 19 0.0009
387 COUGH 242 0.0009
388 STRESS CARDIOMYOPATHY 5 0.0009
389 RASH MACULO-PAPULAR 19 0.0009
390 FLANK PAIN 8 0.0009
391 INTERSTITIAL LUNG DISEASE 41 0.0008
392 CARDIAC TAMPONADE 4 0.0008
393 GOUT 15 0.0008
394 HYPERTHYROIDISM 12 0.0008
395 RESTLESS LEGS SYNDROME 15 0.0008
396 ASTHMATIC CRISIS 3 0.0008
397 THROMBOTIC MICROANGIOPATHY 8 0.0008
398 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
399 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
400 ORTHOSTATIC HYPOTENSION 14 0.0008
401 HYPOTONIA 8 0.0008
402 PNEUMONIA ASPIRATION 20 0.0008
403 DERMATITIS EXFOLIATIVE 4 0.0008
404 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
405 BRAIN INJURY 8 0.0008
406 PEMPHIGOID 6 0.0008
407 MENTAL STATUS CHANGES 22 0.0008
408 FACE INJURY 3 0.0008
409 PLEURAL EFFUSION 48 0.0008
410 PARANASAL SINUS HYPERSECRETION 3 0.0008
411 HEPATIC CYTOLYSIS 10 0.0008
412 DISSOCIATION 6 0.0008
413 ABDOMINAL PAIN UPPER 161 0.0008
414 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
415 HYPOKALAEMIA 36 0.0008
416 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
417 OROPHARYNGEAL DISCOMFORT 7 0.0008
418 APHTHOUS ULCER 6 0.0008
419 PERIORBITAL OEDEMA 4 0.0008
420 MALABSORPTION 4 0.0008
421 PNEUMONIA BACTERIAL 7 0.0008
422 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
423 BLOOD LACTIC ACID INCREASED 4 0.0008
424 SUICIDE ATTEMPT 46 0.0008
425 MULTI-ORGAN FAILURE 13 0.0008
426 RENAL IMPAIRMENT 63 0.0007
427 SKIN MASS 5 0.0007
428 CARDIOVASCULAR DISORDER 19 0.0007
429 SENSORY LOSS 6 0.0007
430 ACUTE KIDNEY INJURY 114 0.0007
431 WRONG PRODUCT ADMINISTERED 5 0.0007
432 ULCER HAEMORRHAGE 5 0.0007
433 PULMONARY OEDEMA 33 0.0007
434 ENCEPHALOPATHY 18 0.0007
435 DECREASED APPETITE 170 0.0007
436 VENTRICULAR TACHYCARDIA 12 0.0007
437 HERNIA 14 0.0007
438 LARGE INTESTINE POLYP 5 0.0007
439 EOSINOPHIL COUNT INCREASED 6 0.0007
440 STEVENS-JOHNSON SYNDROME 16 0.0007
441 C-REACTIVE PROTEIN INCREASED 26 0.0007
442 HAEMODIALYSIS 6 0.0007
443 ANGIOPATHY 4 0.0007
444 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
445 FALL 237 0.0007
446 HYPONATRAEMIA 40 0.0007
447 RETINAL HAEMORRHAGE 5 0.0007
448 BLOOD MAGNESIUM DECREASED 6 0.0007
449 INSOMNIA 185 0.0007
450 PNEUMOTHORAX 11 0.0007
451 MONOPLEGIA 3 0.0007
452 RALES 4 0.0007
453 RASH PUSTULAR 5 0.0007
454 URINE OUTPUT DECREASED 6 0.0007
455 SLEEP APNOEA SYNDROME 13 0.0007
456 ACUTE MYOCARDIAL INFARCTION 20 0.0007
457 ILEUS PARALYTIC 3 0.0007
458 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
459 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
460 MIGRAINE 63 0.0007
461 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
462 TROPONIN INCREASED 5 0.0007
463 BLOOD UREA INCREASED 11 0.0007
464 ANAPHYLACTIC REACTION 36 0.0007
465 WOUND 18 0.0006
466 MULTIPLE MYELOMA 3 0.0006
467 MIDDLE INSOMNIA 12 0.0006
468 CEREBRAL HAEMORRHAGE 23 0.0006
469 THERAPEUTIC RESPONSE CHANGED 4 0.0006
470 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
471 DYSPNOEA 357 0.0006
472 DISEASE RECURRENCE 30 0.0006
473 LOW BIRTH WEIGHT BABY 5 0.0006
474 HYPERTENSIVE CRISIS 7 0.0006
475 EYE INFLAMMATION 6 0.0006
476 ULCER 10 0.0006
477 CORONARY ARTERY DISEASE 19 0.0006
478 OVERDOSE 135 0.0006
479 CHOLESTASIS 12 0.0006
480 ACUTE RESPIRATORY FAILURE 12 0.0006
481 BLOOD CALCIUM DECREASED 7 0.0006
482 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
483 CARDIAC FLUTTER 4 0.0006
484 NEURALGIA 15 0.0006
485 RENAL FAILURE ACUTE 26 0.0006
486 RENAL FAILURE 81 0.0006
487 DYSPEPSIA 60 0.0006
488 ASTHENIA 229 0.0006
489 BREATH SOUNDS ABNORMAL 3 0.0006
490 LEUKOCYTOSIS 11 0.0006
491 PALPITATIONS 71 0.0006
492 HYPERNATRAEMIA 3 0.0006
493 PRURITUS 228 0.0006
494 AGRANULOCYTOSIS 11 0.0006
495 OSTEOARTHRITIS 25 0.0006
496 DIZZINESS 293 0.0006
497 PHLEBITIS 3 0.0006
498 HYPERLIPIDAEMIA 7 0.0006
499 FEMORAL NECK FRACTURE 3 0.0006
500 LIVER FUNCTION TEST ABNORMAL 17 0.0006
501 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
502 INTESTINAL OBSTRUCTION 22 0.0006
503 BLOOD PRESSURE FLUCTUATION 14 0.0006
504 CACHEXIA 3 0.0006
505 PERIPHERAL COLDNESS 8 0.0006
506 ANAPHYLACTIC SHOCK 15 0.0006
507 CARDIAC MURMUR 5 0.0006
508 RESPIRATORY DISORDER 17 0.0006
509 TREATMENT FAILURE 47 0.0006
510 RENAL PAIN 6 0.0006
511 HYPOTHYROIDISM 18 0.0006
512 HEPATIC FUNCTION ABNORMAL 21 0.0006
513 PYREXIA 194 0.0006
514 GINGIVITIS 3 0.0006
515 BLOOD POTASSIUM INCREASED 9 0.0006
516 END STAGE RENAL DISEASE 10 0.0005
517 ERECTILE DYSFUNCTION 14 0.0005
518 CARDIOMYOPATHY 8 0.0005
519 COAGULOPATHY 9 0.0005
520 COLON CANCER 8 0.0005
521 PERICARDITIS 9 0.0005
522 DEAFNESS 14 0.0005
523 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
524 CHOLECYSTITIS ACUTE 3 0.0005
525 HYPOCALCAEMIA 10 0.0005
526 PULMONARY HYPERTENSION 11 0.0005
527 CARDIAC VALVE DISEASE 3 0.0005
528 LIPASE INCREASED 4 0.0005
529 EXERCISE TOLERANCE DECREASED 3 0.0005
530 ENTEROCOLITIS 3 0.0005
531 VOMITING 244 0.0005
532 CONCUSSION 4 0.0005
533 HYPOALBUMINAEMIA 4 0.0005
534 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
535 RENAL TUBULAR NECROSIS 5 0.0005
536 HEPATOMEGALY 5 0.0005
537 VERTIGO 31 0.0005
538 MALAISE 223 0.0005
539 ARTHRALGIA 211 0.0005
540 LIGAMENT SPRAIN 5 0.0005
541 BLOOD ALBUMIN DECREASED 4 0.0005
542 UNRESPONSIVE TO STIMULI 13 0.0005
543 BLOOD PRESSURE ABNORMAL 10 0.0005
544 HAEMOPTYSIS 14 0.0005
545 OEDEMA PERIPHERAL 61 0.0005
546 GANGRENE 3 0.0005
547 MUSCLE DISORDER 4 0.0005
548 DERMATITIS ACNEIFORM 3 0.0005
549 SUBARACHNOID HAEMORRHAGE 5 0.0005
550 SEPTIC SHOCK 21 0.0005
551 PRE-EXISTING CONDITION IMPROVED 3 0.0005
552 BLOOD SODIUM DECREASED 9 0.0005
553 URINARY INCONTINENCE 14 0.0005
554 LETHARGY 27 0.0005
555 BLOOD POTASSIUM DECREASED 14 0.0005
556 BLOOD CALCIUM INCREASED 4 0.0005
557 EPISTAXIS 34 0.0005
558 HYPOGLYCAEMIA 22 0.0005
559 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
560 LUNG DISORDER 22 0.0004
561 WRONG DRUG ADMINISTERED 4 0.0004
562 CARDIOTOXICITY 4 0.0004
563 HAEMARTHROSIS 4 0.0004
564 NAUSEA 353 0.0004
565 INFLAMMATION 23 0.0004
566 OSTEOMYELITIS 8 0.0004
567 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
568 GINGIVAL BLEEDING 6 0.0004
569 MENTAL DISORDER 19 0.0004
570 GASTRIC HAEMORRHAGE 5 0.0004
571 HEPATIC FAILURE 13 0.0004
572 EXTRASYSTOLES 3 0.0004
573 RIGHT VENTRICULAR FAILURE 3 0.0004
574 DISTURBANCE IN ATTENTION 23 0.0004
575 SKIN ULCER 11 0.0004
576 DUODENAL ULCER 3 0.0004
577 LYMPHOPENIA 6 0.0004
578 HEART RATE INCREASED 42 0.0004
579 PHOTOSENSITIVITY REACTION 7 0.0004
580 HAND FRACTURE 3 0.0004
581 BRONCHOSPASM 6 0.0004
582 DIARRHOEA 271 0.0004
583 PRODUCT PRESCRIBING ERROR 10 0.0004
584 GASTRITIS 11 0.0004
585 NERVOUS SYSTEM DISORDER 13 0.0004
586 SWOLLEN TONGUE 13 0.0004
587 FACE OEDEMA 7 0.0004
588 FAECES SOFT 3 0.0004
589 PANIC ATTACK 15 0.0004
590 VITAMIN D DEFICIENCY 4 0.0004
591 ACCIDENTAL OVERDOSE 15 0.0004
592 NO THERAPEUTIC RESPONSE 5 0.0004
593 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
594 PHARYNGEAL SWELLING 4 0.0004
595 RESPIRATORY DEPRESSION 5 0.0004
596 HYPOPHOSPHATAEMIA 3 0.0004
597 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
598 ARTHROPOD BITE 3 0.0004
599 PALLOR 11 0.0004
600 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
601 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
602 DIVERTICULITIS 11 0.0004
603 LYMPHOCYTE COUNT DECREASED 7 0.0004
604 MEDICATION ERROR 22 0.0004
605 RECTAL HAEMORRHAGE 17 0.0004
606 CEREBROVASCULAR ACCIDENT 67 0.0004
607 HEPATOCELLULAR CARCINOMA 3 0.0004
608 ARTHRITIS 31 0.0004
609 PROCEDURAL COMPLICATION 3 0.0004
610 LIP SWELLING 13 0.0004
611 MYDRIASIS 5 0.0004
612 PERICARDIAL EFFUSION 9 0.0004
613 EJECTION FRACTION DECREASED 6 0.0004
614 CARDIAC FAILURE CONGESTIVE 31 0.0004
615 DRUG INTOLERANCE 37 0.0004
616 HAEMATOCHEZIA 21 0.0004
617 GENERAL PHYSICAL HEALTH DETERIORATION 44 0.0004
618 HEADACHE 238 0.0004
619 DISORIENTATION 15 0.0004
620 DYSARTHRIA 14 0.0004
621 SKIN DISCOLOURATION 17 0.0004
622 GASTRIC ULCER 7 0.0004
623 BACK INJURY 4 0.0004
624 BLOOD CREATININE INCREASED 24 0.0004
625 ASPHYXIA 3 0.0004
626 PNEUMONITIS 10 0.0004
627 PULMONARY FIBROSIS 7 0.0004
628 RESPIRATORY ARREST 10 0.0004
629 ACUTE CORONARY SYNDROME 3 0.0004
630 CHEST PAIN 67 0.0004
631 ANGIOEDEMA 16 0.0004
632 SECOND PRIMARY MALIGNANCY 3 0.0004
633 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
634 MALNUTRITION 4 0.0004
635 CARPAL TUNNEL SYNDROME 5 0.0004
636 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
637 FATIGUE 277 0.0004
638 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
639 SCAR 6 0.0004
640 SUBDURAL HAEMATOMA 5 0.0003
641 MYOPATHY 3 0.0003
642 PARAESTHESIA ORAL 5 0.0003
643 PRODUCT ADMINISTRATION ERROR 7 0.0003
644 VASCULITIS 4 0.0003
645 PURPURA 3 0.0003
646 BACTERAEMIA 4 0.0003
647 ANAEMIA 64 0.0003
648 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
649 PREMATURE BABY 10 0.0003
650 HYPERTENSION 70 0.0003
651 MOOD ALTERED 9 0.0003
652 LOSS OF CONSCIOUSNESS 42 0.0003
653 POOR QUALITY SLEEP 7 0.0003
654 HYPERCALCAEMIA 4 0.0003
655 TENDONITIS 5 0.0003
656 FAECES DISCOLOURED 7 0.0003
657 HEPATIC STEATOSIS 6 0.0003
658 ERYTHEMA MULTIFORME 3 0.0003
659 DIARRHOEA HAEMORRHAGIC 3 0.0003
660 BLISTER 18 0.0003
661 ARTERIOSCLEROSIS 3 0.0003
662 LEUKAEMIA 3 0.0003
663 CONFUSIONAL STATE 51 0.0003
664 STOMATITIS 19 0.0003
665 PRODUCT SUBSTITUTION ISSUE 18 0.0003
666 ANOREXIA 4 0.0003
667 HIATUS HERNIA 4 0.0003
668 PRODUCT USE ISSUE 58 0.0003
669 MUSCULOSKELETAL STIFFNESS 27 0.0003
670 WEIGHT DECREASED 86 0.0003
671 KIDNEY INFECTION 6 0.0003
672 DYSPHAGIA 29 0.0003
673 NECK PAIN 17 0.0003
674 PANCREATITIS 16 0.0003
675 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
676 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
677 EAR INFECTION 8 0.0003
678 EYE HAEMORRHAGE 4 0.0003
679 HAIR TEXTURE ABNORMAL 4 0.0003
680 PNEUMONIA 96 0.0003
681 HYPOTHERMIA 3 0.0003
682 RASH PRURITIC 16 0.0003
683 DRUG LEVEL DECREASED 3 0.0003
684 RASH ERYTHEMATOUS 14 0.0003
685 ACUTE HEPATIC FAILURE 4 0.0003
686 CORONARY ARTERY OCCLUSION 4 0.0003
687 LIMB DISCOMFORT 9 0.0003
688 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
689 CHRONIC KIDNEY DISEASE 22 0.0003
690 THROMBOSIS 23 0.0003
691 SCRATCH 3 0.0003
692 CHEST DISCOMFORT 29 0.0003
693 ASTHMA 32 0.0003
694 LYMPHADENOPATHY 10 0.0003
695 BODY HEIGHT DECREASED 3 0.0003
696 RED BLOOD CELL COUNT DECREASED 8 0.0003
697 GASTROINTESTINAL DISORDER 25 0.0003
698 DECREASED ACTIVITY 3 0.0003
699 DEHYDRATION 37 0.0003
700 THROMBOCYTOPENIA 31 0.0003
701 HYPOKINESIA 4 0.0003
702 APATHY 4 0.0003
703 GASTROENTERITIS 4 0.0003
704 DRY MOUTH 22 0.0003
705 WHEEZING 16 0.0003
706 CONJUNCTIVITIS 5 0.0003
707 HEPATOTOXICITY 6 0.0003
708 HAEMORRHAGE INTRACRANIAL 4 0.0003
709 INTESTINAL PERFORATION 3 0.0003
710 CONDITION AGGRAVATED 81 0.0003
711 DRUG ABUSE 22 0.0003
712 FOOT FRACTURE 5 0.0003
713 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
714 CHOLECYSTECTOMY 3 0.0003
715 ABDOMINAL DISCOMFORT 44 0.0003
716 CONVULSION 15 0.0003
717 DEEP VEIN THROMBOSIS 17 0.0003
718 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
719 PHARYNGEAL OEDEMA 4 0.0003
720 GLAUCOMA 5 0.0003
721 THYROID DISORDER 4 0.0003
722 FEMUR FRACTURE 8 0.0003
723 OEDEMA 14 0.0003
724 EYELID OEDEMA 3 0.0003
725 LIMB INJURY 7 0.0003
726 COGNITIVE DISORDER 12 0.0003
727 CONSTIPATION 56 0.0003
728 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
729 HAEMORRHOIDS 5 0.0003
730 HYPERHIDROSIS 33 0.0003
731 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
732 HAEMATOCRIT DECREASED 5 0.0003
733 OBESITY 4 0.0003
734 MULTIPLE SCLEROSIS 12 0.0003
735 ADRENAL INSUFFICIENCY 3 0.0002
736 OFF LABEL USE 216 0.0002
737 CARDIAC DISORDER 23 0.0002
738 CYTOPENIA 3 0.0002
739 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
740 PLATELET COUNT DECREASED 26 0.0002
741 STAPHYLOCOCCAL INFECTION 8 0.0002
742 PHARYNGITIS 3 0.0002
743 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
744 CYTOMEGALOVIRUS INFECTION 4 0.0002
745 ABDOMINAL DISTENSION 25 0.0002
746 COLITIS 9 0.0002
747 DEPRESSION 54 0.0002
748 ANGER 8 0.0002
749 RENAL DISORDER 11 0.0002
750 INJECTION SITE IRRITATION 3 0.0002
751 JOINT INJURY 5 0.0002
752 MUSCULOSKELETAL DISCOMFORT 4 0.0002
753 INJECTION SITE INDURATION 3 0.0002
754 PRODUCT DISPENSING ERROR 5 0.0002
755 BEDRIDDEN 3 0.0002
756 ORAL CANDIDIASIS 3 0.0002
757 COLD SWEAT 4 0.0002
758 SLEEP DISORDER 16 0.0002
759 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
760 LIVER DISORDER 10 0.0002
761 TRANSAMINASES INCREASED 5 0.0002
762 THIRST 4 0.0002
763 BLOOD BILIRUBIN INCREASED 6 0.0002
764 THROAT TIGHTNESS 6 0.0002
765 MUSCULAR WEAKNESS 25 0.0002
766 LEUKOPENIA 11 0.0002
767 OSTEOPOROSIS 9 0.0002
768 CONTUSION 21 0.0002
769 ABNORMAL DREAMS 6 0.0002
770 BRONCHITIS 16 0.0002
771 ORAL DISCOMFORT 3 0.0002
772 HUNGER 3 0.0002
773 APHONIA 3 0.0002
774 BLOOD CHOLESTEROL INCREASED 10 0.0002
775 CHOLELITHIASIS 7 0.0002
776 BLINDNESS UNILATERAL 3 0.0002
777 FLATULENCE 12 0.0002
778 DIALYSIS 3 0.0002
779 FRACTURE 4 0.0002
780 URINARY TRACT INFECTION 36 0.0002
781 PROTEINURIA 4 0.0002
782 MUSCULOSKELETAL DISORDER 4 0.0002
783 VISUAL IMPAIRMENT 26 0.0002
784 GAIT DISTURBANCE 40 0.0002
785 MYELODYSPLASTIC SYNDROME 3 0.0002
786 LOCALISED INFECTION 5 0.0002
787 PRESCRIBED OVERDOSE 4 0.0002
788 MENTAL IMPAIRMENT 5 0.0002
789 SKIN FISSURES 4 0.0002
790 PARAESTHESIA 32 0.0002
791 NIGHTMARE 7 0.0002
792 DELIRIUM 7 0.0002
793 INFECTION 29 0.0002
794 DRY EYE 10 0.0002
795 HALLUCINATION 15 0.0002
796 HYPOAESTHESIA ORAL 3 0.0002
797 TREMOR 33 0.0002
798 NEUTROPENIA 27 0.0002
799 ABDOMINAL PAIN LOWER 5 0.0002
800 GASTRIC CANCER 5 0.0002
801 INFLUENZA 22 0.0002
802 PAIN IN EXTREMITY 58 0.0002
803 MEMORY IMPAIRMENT 27 0.0002
804 DRUG DISPENSING ERROR 3 0.0002
805 DEVICE RELATED INFECTION 3 0.0002
806 HAEMOGLOBIN DECREASED 20 0.0002
807 ANXIETY 55 0.0002
808 PERITONITIS 4 0.0002
809 RESPIRATORY TRACT INFECTION 5 0.0002
810 RESTLESSNESS 7 0.0002
811 DRUG-INDUCED LIVER INJURY 6 0.0002
812 ECZEMA 10 0.0002
813 MOUTH ULCERATION 4 0.0002
814 PULMONARY EMBOLISM 18 0.0002
815 NEUROPATHY PERIPHERAL 18 0.0002
816 MYOCARDIAL INFARCTION 33 0.0002
817 PERIPHERAL SWELLING 29 0.0002
818 SCIATICA 3 0.0002
819 EATING DISORDER 4 0.0002
820 IRRITABLE BOWEL SYNDROME 4 0.0002
821 LIVER FUNCTION TEST INCREASED 4 0.0002
822 HOT FLUSH 14 0.0002
823 INTENTIONAL PRODUCT MISUSE 16 0.0002
824 SKIN LESION 5 0.0002
825 HAEMORRHAGE 19 0.0002
826 FEELING COLD 5 0.0002
827 FEELING HOT 11 0.0002
828 THROAT IRRITATION 8 0.0002
829 PANCREATITIS ACUTE 4 0.0002
830 HEMIPARESIS 3 0.0002
831 PRODUCT AVAILABILITY ISSUE 4 0.0002
832 URTICARIA 29 0.0002
833 DRUG INEFFECTIVE 228 0.0002
834 NEOPLASM PROGRESSION 6 0.0002
835 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
836 DYSSTASIA 5 0.0002
837 DYSPHONIA 10 0.0002
838 BONE PAIN 10 0.0002
839 DIABETES MELLITUS 13 0.0002
840 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
841 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
842 PRODUCTIVE COUGH 8 0.0002
843 RASH 72 0.0002
844 FIBROMYALGIA 4 0.0002
845 SUICIDAL IDEATION 15 0.0002
846 AGITATION 12 0.0002
847 INCORRECT DOSE ADMINISTERED 37 0.0002
848 DISEASE PROGRESSION 19 0.0002
849 OXYGEN SATURATION DECREASED 9 0.0002
850 HEPATIC CIRRHOSIS 3 0.0002
851 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
852 HEAD INJURY 5 0.0002
853 CYSTITIS 5 0.0002
854 BURNING SENSATION 11 0.0002
855 HYPOPHAGIA 4 0.0002
856 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
857 MOVEMENT DISORDER 5 0.0002
858 RASH GENERALISED 4 0.0002
859 EAR PAIN 3 0.0002
860 ORAL HERPES 3 0.0002
861 SWELLING FACE 10 0.0002
862 NASAL CONGESTION 9 0.0002
863 NERVOUSNESS 8 0.0002
864 JOINT STIFFNESS 4 0.0002
865 CATARACT 9 0.0002
866 HYPERSENSITIVITY 28 0.0002
867 ERYTHEMA 31 0.0002
868 BACK PAIN 35 0.0002
869 VISUAL ACUITY REDUCED 5 0.0002
870 BALANCE DISORDER 13 0.0002
871 PRESCRIBED UNDERDOSE 3 0.0002
872 VIRAL INFECTION 5 0.0002
873 FUNGAL INFECTION 5 0.0001
874 SKIN DISORDER 5 0.0001
875 URINARY RETENTION 5 0.0001
876 PRODUCT PHYSICAL ISSUE 3 0.0001
877 JAUNDICE 4 0.0001
878 FREQUENT BOWEL MOVEMENTS 4 0.0001
879 FEELING ABNORMAL 35 0.0001
880 RIB FRACTURE 3 0.0001
881 UNEVALUABLE EVENT 11 0.0001
882 PANCYTOPENIA 8 0.0001
883 WEIGHT INCREASED 32 0.0001
884 NASOPHARYNGITIS 26 0.0001
885 RHEUMATOID ARTHRITIS 16 0.0001
886 PRURITUS GENERALISED 3 0.0001
887 SEIZURE 16 0.0001
888 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
889 CRYING 5 0.0001
890 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
891 FEBRILE NEUTROPENIA 9 0.0001
892 RENAL INJURY 4 0.0001
893 RASH PAPULAR 3 0.0001
894 HYPOAESTHESIA 20 0.0001
895 ADVERSE DRUG REACTION 12 0.0001
896 SPEECH DISORDER 7 0.0001
897 CHROMATURIA 3 0.0001
898 BLOOD GLUCOSE INCREASED 25 0.0001
899 DEPRESSED MOOD 7 0.0001
900 PAIN 81 0.0001
901 ILL-DEFINED DISORDER 8 0.0001
902 MUSCLE TWITCHING 3 0.0001
903 INJURY 9 0.0001
904 TREATMENT NONCOMPLIANCE 7 0.0001
905 FLUSHING 13 0.0001
906 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
907 OCULAR HYPERAEMIA 6 0.0001
908 DIABETIC KETOACIDOSIS 3 0.0001
909 HIP FRACTURE 4 0.0001
910 DYSKINESIA 5 0.0001
911 EYE DISORDER 4 0.0001
912 LUNG NEOPLASM MALIGNANT 5 0.0001
913 EYE IRRITATION 7 0.0001
914 OSTEONECROSIS OF JAW 3 0.0001
915 AGGRESSION 6 0.0001
916 DRY SKIN 16 0.0001
917 COVID-19 21 0.0001
918 ROAD TRAFFIC ACCIDENT 5 0.0001
919 CELLULITIS 6 0.0001
920 HEPATITIS 3 0.0001
921 HYPOACUSIS 5 0.0001
922 JOINT SWELLING 14 0.0001
923 EMOTIONAL DISTRESS 14 0.0001
924 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
925 SEDATION 3 0.0001
926 MUSCULOSKELETAL PAIN 6 0.0001
927 DERMATITIS ATOPIC 6 0.0001
928 BREAST CANCER FEMALE 3 0.0001
929 FEAR 3 0.0001
930 DRUG EFFECT DECREASED 6 0.0001
931 MUSCLE SPASMS 20 0.0001
932 DYSURIA 4 0.0001
933 RHINORRHOEA 7 0.0001
934 OROPHARYNGEAL PAIN 10 0.0001
935 DEMENTIA 3 0.0001
936 SWELLING 10 0.0001
937 ILLNESS 11 0.0001
938 INJECTION SITE PRURITUS 7 0.0001
939 BLOOD GLUCOSE DECREASED 5 0.0001
940 DRUG WITHDRAWAL SYNDROME 9 0.0001
941 ALOPECIA 20 0.0001
942 IRRITABILITY 6 0.0001
943 APHASIA 3 0.0001
944 LACRIMATION INCREASED 3 0.0001
945 THERAPEUTIC RESPONSE DECREASED 6 0.0001
946 FLUID RETENTION 5 0.0001
947 NEUTROPHIL COUNT DECREASED 4 0.0001
948 SINUSITIS 10 0.0001
949 EXPOSURE DURING PREGNANCY 6 0.0001
950 POLLAKIURIA 4 0.0001
951 SKIN EXFOLIATION 8 0.0001
952 IMPAIRED HEALING 3 0.0001
953 OSTEONECROSIS 3 0.0001
954 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
955 EXPIRED PRODUCT ADMINISTERED 3 0.0001
956 ARTHROPATHY 5 0.0001
957 INJECTION SITE ERYTHEMA 11 0.0001
958 HEPATIC ENZYME INCREASED 6 0.0001
959 NEPHROLITHIASIS 4 0.0001
960 PROSTATE CANCER 7 0.0001
961 HERPES ZOSTER 5 0.0001
962 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
963 DEATH 74 0.0001
964 MOBILITY DECREASED 6 0.0001
965 UNDERDOSE 6 0.0001
966 DISCOMFORT 5 0.0001
967 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
968 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
969 PLASMA CELL MYELOMA 3 0.0001
970 AMNESIA 5 0.0001
971 PSORIASIS 10 0.0001
972 ADVERSE EVENT 7 0.0001
973 INFUSION RELATED REACTION 5 0.0001
974 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
975 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
976 DYSGEUSIA 5 0.0001
977 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
978 HOSPITALISATION 10 0.0001
979 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
980 INFLUENZA LIKE ILLNESS 5 0.0001
981 PRODUCT DOSE OMISSION ISSUE 17 0.0001
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
983 BREAST CANCER 4 0.0000
984 PRODUCT STORAGE ERROR 3 0.0000
985 PRODUCT QUALITY ISSUE 4 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 NO ADVERSE EVENT 5 0.0000
988 INJECTION SITE PAIN 8 0.0000
989 DRUG DOSE OMISSION 3 0.0000